Related Articles
Successful treatment with trastuzumab plus chemotherapy as the first‑line regimen in advanced small bowel adenocarcinoma harboring HER2 amplification: A report of two cases
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi Arabia
Non‑synchronous bilateral metastatic ovarian cancer originating from small bowel adenocarcinoma with multidisciplinary treatment: A case report
Feasibility and safety of platinum‑doublet therapy in patients with small‑cell lung cancer in the third‑line setting: <br />A multi‑institutional retrospective study
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status